We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.09B
AUM Growth
-$257M
Cap. Flow
-$296M
Cap. Flow %
-3.26%
Top 10 Hldgs %
15.99%
Holding
2,485
New
64
Increased
214
Reduced
993
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.97%
2 Financials 14.88%
3 Healthcare 12.5%
4 Industrials 10.33%
5 Consumer Discretionary 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAG
1926
DELISTED
Jagged Peak Energy Inc.
JAG
$207K ﹤0.01%
28,571
ALEC icon
1927
Alector
ALEC
$228M
$207K ﹤0.01%
+14,366
New +$259K
KURA icon
1928
Kura Oncology
KURA
$896M
$207K ﹤0.01%
13,652
CNR
1929
Core Natural Resources Inc
CNR
$4.64B
$207K ﹤0.01%
13,213
RGP icon
1930
Resources Connection
RGP
$145M
$205K ﹤0.01%
12,083
LVGO
1931
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$205K ﹤0.01%
+11,765
New +$356K
CHUY
1932
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$205K ﹤0.01%
8,272
CIVI
1933
DELISTED
Civitas Resources
CIVI
$205K ﹤0.01%
9,142
KOP icon
1934
Koppers
KOP
$874M
$205K ﹤0.01%
7,004
-3,261
-32% -$90.4K
BZH icon
1935
Beazer Homes USA
BZH
$874M
$204K ﹤0.01%
13,700
COWN
1936
DELISTED
Cowen Inc. Class A Common Stock
COWN
$203K ﹤0.01%
13,196
HWKN icon
1937
Hawkins
HWKN
$2.67B
$203K ﹤0.01%
9,556
NIC icon
1938
Nicolet Bankshares
NIC
$3.73B
$202K ﹤0.01%
3,028
-1,382
-31% -$89.2K
CTMX icon
1939
CytomX Therapeutics
CTMX
$730M
$201K ﹤0.01%
27,302
FMBH icon
1940
First Mid Bancshares
FMBH
$1.39B
$201K ﹤0.01%
5,809
WINA icon
1941
Winmark
WINA
$1.26B
$201K ﹤0.01%
1,140
AXNX
1942
DELISTED
Axonics, Inc. Common Stock
AXNX
$201K ﹤0.01%
7,468
EIDX
1943
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$201K ﹤0.01%
5,576
-2,877
-34% -$112K
DMRC icon
1944
Digimarc Corp
DMRC
$158M
$200K ﹤0.01%
5,123
SPTN
1945
DELISTED
SpartanNash
SPTN
$200K ﹤0.01%
16,917
BY icon
1946
Byline Bancorp
BY
$1.78B
$199K ﹤0.01%
11,156
CYRX icon
1947
CryoPort
CYRX
$766M
$199K ﹤0.01%
12,188
MGNI icon
1948
Magnite
MGNI
$3.53B
$199K ﹤0.01%
+22,854
New +$200K
MOV icon
1949
Movado Group
MOV
$796M
$198K ﹤0.01%
7,984
DFIN icon
1950
Donnelley Financial Solutions
DFIN
$1.22B
$198K ﹤0.01%
16,100

Similar funds

MetLife Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, MetLife Investment Management held 2,485 positions worth $9.09B, down 2.8% from $9.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management withdrew a net $296M in Q3 2019, closing 157 positions and reducing 993 holdings. Its most notable exit was Anadarko Petroleum, an estimated $9.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in T-Mobile US worth $6.78M.

  • MetLife Investment Management's largest Q3 2019 buy was T-Mobile US: 86,035 shares worth $6.78M.
  • MetLife Investment Management added most to Fidelity National Information Services in Q3 2019, an estimated $10.3M increase.
  • MetLife Investment Management's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $66.2M.
  • MetLife Investment Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $9.77M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.09B portfolio in Q3 2019.
  • MetLife Investment Management opened 64 new positions and closed 157 in Q3 2019.
  • MetLife Investment Management's portfolio value fell 2.8% quarter-over-quarter to $9.09B.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.